Page 219 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice

Disorders of Phosphorus: Hypophosphatemia and Hyperphosphatemia 209

3
90. Korkor AB. Reduced binding of [ H]1,25-dihydrox- 111. Meyer DJ, Terrell TG. Idiopathic hypoparathyroidism in a
yvitamin D 3 in the parathyroid glands of patients with dog. J Am Vet Med Assoc 1976;168:858–60.
renal failure. N Engl J Med 1987;316:1573. 112. Moe S. Disorders involving calcium, phosphorus and mag-
91. Kreisberg RA. Phosphorus deficiency and nesium. Prim Care Clin Office Pract 2008;35:215–37.
hypophosphatemia. Hosp Pract 1977;12:121–8. 113. Molitoris BA, Froment DH, MacKenzie TA, et al. Citrate:
92. Kristensen AT, Klausner JS, Weiss DJ, et al. Spurious a major factor in the toxicity of orally administered alumi-
hyperphosphatemia in a dog with chronic lymphocytic num compounds. Kidney Int 1989;36:949–53.
leukemia and an IgM monoclonal gammopathy. Vet Clin 114. Moore FM, Kudisch M, Richter K, et al. Hypercalcemia
Pathol 1991;20:45–8. associated with rodenticide poisoning in three cats.
93. Laing EJ, Carter RF. Acute tumor lysis syndrome follow- J Am Vet Med Assoc 1988;193:1099–100.
ing treatment of canine lymphoma. J Am Anim Hosp 115. Murer H, Hernando N, Forster I, et al. Proximal tubular
Assoc 1988;24:691–6. phosphate reabsorption: molecular mechanisms. Physiol
94. Laing EJ, Fitzpatrick PJ, Norris AM, et al. Half-body Rev 2000;80:1373–409.
radiotherapy in the treatment of canine lymphoma. 116. Nafidi O, Lapointe R, Lepage R, et al. Mechanisms of
J Vet Intern Med 1989;3:102–8. renal phosphate loss in liver resection-associated
95. Lane J, Rehak N, Hortin G, et al. Pseudohyperpho- hypophosphatemia. Ann Surg 2009;249:824–7.
sphatemia associated with high-dose liposomal 117. Nagode LA, Chew DJ, Podell M. Benefits of calcitriol
amphotericin B therapy. Clin Chim Acta 2008;387:145–9. therapy and serum phosphorus control in dogs and
96. Laroche M, Boyer J. Phosphate diabetes, tubular phos- cats with renal failure. Vet Clin North Am
phate reabsorption and phosphatonins. Joint Bone Spine 1996;26:1293–13330.
2005;72:376–81. 118. Ori Y, Herman M, Tobar A, et al. Acute phosphate
97. Leehey DJ, Daugirdas JT, Ing TS, et al. Spurious nephropathy: an emerging threat. Am J Med Sci
hyperphosphatemia due to hyperlipidemia. Arch Intern 2008;336:309–14.
Med 1985;145:743–4. 119. Oster JR, Perez GO, Vaamonde CA. Relationship
98. Legendre AM, Merkley DF, Carrig CB, et al. Primary between blood pH and potassium and phosphorus during
hyperparathyroidism in a dog. J Am Vet Med Assoc acute metabolic acidosis. Am J Physiol 1978;235:
1976;168:694–6. F345–F351.
99. Levine BS, Kleeman CR. Hypophosphatemia and 120. Page RL, Leifer CE, Matus RE. Uric acid and phosphorus
hyperphosphatemia: clinical and pathophysiologic excretion in dogs with lymphosarcoma. Am J Vet Res
aspects. In: Narins RG, editor. Clinical disorders of fluid 1986;47:910–2.
and electrolyte metabolism. 5th ed. New York: 121. Parkinson IS, Ward MK, Kerr DNS. Dialysis encephalo-
McGraw-Hill; 1994. p. 1045–1090. pathy, bone disease, and anemia: the aluminum intoxica-
100. Lopez S, Galceran T, Slatopolsky E. Evaluation of calcium tion syndrome during regular hemodialysis. J Clin Pathol
carbonate as an effective phosphorus-binding agent in the 1981;34:1285–94.
dog. Clin Res 1984;32:452A. 122. Partridge NA, Regnier FE, White JL, et al. Influence of
101. Lotz M, Zisman E, Bartter FC. Evidence for a phosphorus dietary constituents on intestinal absorption of aluminum.
depletion syndrome in man. N Engl J Med Kidney Int 1989;35:1413–7.
1968;278:409–15. 123. Paster E, Mehl M, Kass P, et al. Hypophosphatemia in cats
102. Lumlertgul D, Burke TJ, Gillum DM, et al. Phosphate after renal transplantation. Vet Surg 2009;38:983–9.
depletion arrests progression of chronic renal failure 124. Pesillo SA, Khan SA, Rozanski EA, et al. Calcipotriene
independent of protein intake. Kidney Int 1986;29:658. toxicosis in a dog successfully treated with pamidronate
103. Lutomski DM, Bower RH. The effect of thrombocytosis disodium. J Vet Emerg Crit Care 2002;12:177–81.
on serum potassium and phosphorus concentrations. Am 125. Peterson ME. Hyperadrenocorticism. Vet Clin North Am
J Med Sci 1994;307:255–8. 1984;14:731–49.
104. MacKenzie CP, Burnie AG, Head KW. Poisoning in four 126. Peterson ME. Endocrine disorders in cats: four emerging
dogs by a compound containing warfarin and calciferol. diseases. Comp Contin Educ Pract Vet 1988;10:1353–62.
J Small Anim Pract 1987;28:433–45. 127. Peterson ME, Kintzer PP, Cavanagh PG, et al. Feline
105. Mai ML, Emmett ME, Sheikh MS, et al. Calcium acetate, hyperthyroidism: pretreatment clinical and laboratory
an effective phosphorus binder in patients with renal evaluation of 131 cases. J Am Vet Med Assoc
failure. Kidney Int 1989;36:690–5. 1983;183:103–10.
106. Malberti F, Surian M, Colussi G, et al. Calcium carbonate: 128. Peterson ME, Taylor RS, Greco DS, et al. Spontaneous
a suitable alternative to aluminum hydroxide as phosphate acromegaly in the cat. In: Proc Am Coll Vet Intern
binder. Kidney Int 1988;33:S184–S185. Med. 1986. p. 14–43. Washington, DC.
107. Marvin V, Brown D, Portlock J, et al. Factors contributing 129. Peterson ME, Taylor RS, Greco DS, et al. Acromegaly in
to the development of hypophosphatemia when 14 cats. J Vet Intern Med 1990;4:192–201.
refeeding using parenteral nutrition. Pharm World Sci 130. Peterson ME, James KM, Wallace M, et al. Idiopathic
2008;30:329–35. hypoparathyroidism in five cats. J Vet Intern Med
108. Mavrikakis M, Vaiopoulos G, Athanassiades P, et al. 1991;5:47–51.
Pseudohyperphosphatemia in multiple myeloma. Am J 131. Pickrell JA, Schluter SJ, Belasich JJ, et al. Relationship of
Hematol 1996;51:178–9. age of normal dogs to blood serum constituents and reli-
109. McNamara PD, Rea CT, Bovee KC, et al. Cystinuria in ability of measured single values. Am J Vet Res
dogs: comparison of the cystinuric component of the 1974;35:897–903.
Fanconi syndrome in basenji dogs to isolated cystinuria. 132. Polderman K, Bloemers F, Peerdeman S, et al. Hypomag-
Metabolism 1989;38:8–15. nesemia and hypophosphatemia at admission in patients
110. Merke J, Hugel U, Zlotkowski A, et al. Diminished with severe head injury. Crit Care Med 2000;28:2022–5.
parathyroid 1,25-dihydroxycholecalciferol receptors in 133. Qunibi WY, Hootkins RE, McDowell LL, et al. Treat-
experimental uremia. Kidney Int 1987;32:350–3. ment of hyperphosphatemia in hemodialysis patients: